Sotatercept Tied to Disease Modification in PAH
Data show sotatercept may deliver significant clinical benefits and could reshape the trajectory of this challenging disease.
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data show sotatercept may deliver significant clinical benefits and could reshape the trajectory of this challenging disease.
Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date; safety profile of sotatercept consistent with previous studies and efficacy improvements maintained after one year of therapy
Exploratory post-hoc analysis of STELLAR shows potential of sotatercept to improve cardiovascular function Interim results from SOTERIA open-label extension study represent longest safety and...
PRINCETON, N.J.--(BUSINESS WIRE)--Aug 28, 2023--
PRINCETON, N.J.--(BUSINESS WIRE)--Aug 28, 2023--